S&P 500   3,263.11 (+0.60%)
DOW   28,639.57 (+0.36%)
QQQ   219.67 (+0.72%)
AAPL   312.70 (+1.21%)
FB   214.54 (-0.15%)
MSFT   164.16 (+1.16%)
GOOGL   1,433.41 (+0.12%)
AMZN   1,839.22 (+0.60%)
CGC   23.24 (+7.79%)
NVDA   242.19 (+0.83%)
BABA   208.73 (+1.59%)
MU   55.62 (+0.38%)
GE   11.53 (+0.79%)
TSLA   566.13 (+1.45%)
AMD   49.87 (+1.24%)
T   38.57 (+0.84%)
ACB   1.96 (+3.71%)
F   8.92 (+0.22%)
NFLX   347.61 (+1.38%)
BAC   33.15 (+0.91%)
DIS   136.33 (+0.31%)
GILD   64.49 (+1.03%)
S&P 500   3,263.11 (+0.60%)
DOW   28,639.57 (+0.36%)
QQQ   219.67 (+0.72%)
AAPL   312.70 (+1.21%)
FB   214.54 (-0.15%)
MSFT   164.16 (+1.16%)
GOOGL   1,433.41 (+0.12%)
AMZN   1,839.22 (+0.60%)
CGC   23.24 (+7.79%)
NVDA   242.19 (+0.83%)
BABA   208.73 (+1.59%)
MU   55.62 (+0.38%)
GE   11.53 (+0.79%)
TSLA   566.13 (+1.45%)
AMD   49.87 (+1.24%)
T   38.57 (+0.84%)
ACB   1.96 (+3.71%)
F   8.92 (+0.22%)
NFLX   347.61 (+1.38%)
BAC   33.15 (+0.91%)
DIS   136.33 (+0.31%)
GILD   64.49 (+1.03%)
S&P 500   3,263.11 (+0.60%)
DOW   28,639.57 (+0.36%)
QQQ   219.67 (+0.72%)
AAPL   312.70 (+1.21%)
FB   214.54 (-0.15%)
MSFT   164.16 (+1.16%)
GOOGL   1,433.41 (+0.12%)
AMZN   1,839.22 (+0.60%)
CGC   23.24 (+7.79%)
NVDA   242.19 (+0.83%)
BABA   208.73 (+1.59%)
MU   55.62 (+0.38%)
GE   11.53 (+0.79%)
TSLA   566.13 (+1.45%)
AMD   49.87 (+1.24%)
T   38.57 (+0.84%)
ACB   1.96 (+3.71%)
F   8.92 (+0.22%)
NFLX   347.61 (+1.38%)
BAC   33.15 (+0.91%)
DIS   136.33 (+0.31%)
GILD   64.49 (+1.03%)
S&P 500   3,263.11 (+0.60%)
DOW   28,639.57 (+0.36%)
QQQ   219.67 (+0.72%)
AAPL   312.70 (+1.21%)
FB   214.54 (-0.15%)
MSFT   164.16 (+1.16%)
GOOGL   1,433.41 (+0.12%)
AMZN   1,839.22 (+0.60%)
CGC   23.24 (+7.79%)
NVDA   242.19 (+0.83%)
BABA   208.73 (+1.59%)
MU   55.62 (+0.38%)
GE   11.53 (+0.79%)
TSLA   566.13 (+1.45%)
AMD   49.87 (+1.24%)
T   38.57 (+0.84%)
ACB   1.96 (+3.71%)
F   8.92 (+0.22%)
NFLX   347.61 (+1.38%)
BAC   33.15 (+0.91%)
DIS   136.33 (+0.31%)
GILD   64.49 (+1.03%)
Log in

ASX:MYX - Mayne Pharma Group Stock Price, Forecast & News

A$0.46
-0.01 (-2.13 %)
(As of 01/28/2020 10:07 AM ET)
Today's Range
A$0.46
Now: A$0.46
A$0.47
50-Day Range
A$0.43
MA: A$0.45
A$0.49
52-Week Range
A$0.43
Now: A$0.46
A$0.87
Volume3.10 million shs
Average Volume6.32 million shs
Market Capitalization$732.95 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products worldwide. It operates through four segments: Generic Products, Specialty Brands, Metrics Contract Services, and Mayne Pharma International. The company also offers oral drug delivery systems; and contract development and manufacturing services to third-party customers. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited is based in Salisbury South, Australia.

Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+61-8-82092666

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$525.21 million
Cash FlowA$0.06 per share
Book ValueA$0.64 per share

Profitability

Miscellaneous

Employees780
Outstanding Shares1,593,379,968
Market Cap$732.95 million
Next Earnings Date2/21/2020 (Estimated)
OptionableNot Optionable

Receive MYX News and Ratings via Email

Sign-up to receive the latest news and ratings for MYX and its competitors with MarketBeat's FREE daily newsletter.


Mayne Pharma Group (ASX:MYX) Frequently Asked Questions

What is Mayne Pharma Group's stock symbol?

Mayne Pharma Group trades on the ASX under the ticker symbol "MYX."

How were Mayne Pharma Group's earnings last quarter?

Mayne Pharma Group Ltd (ASX:MYX) posted its quarterly earnings data on Friday, February, 22nd. The company reported $0.02 earnings per share (EPS) for the quarter. View Mayne Pharma Group's Earnings History.

When is Mayne Pharma Group's next earnings date?

Mayne Pharma Group is scheduled to release their next quarterly earnings announcement on Friday, February 21st 2020. View Earnings Estimates for Mayne Pharma Group.

Has Mayne Pharma Group been receiving favorable news coverage?

Headlines about MYX stock have been trending somewhat negative this week, InfoTrie Sentiment reports. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Mayne Pharma Group earned a news sentiment score of -1.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the next few days. View News Stories for Mayne Pharma Group.

Who are some of Mayne Pharma Group's key competitors?

What other stocks do shareholders of Mayne Pharma Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mayne Pharma Group investors own include Turquoise Hill Resources (TRQ), Aurora Cannabis (ACB), SUNDANCE ENERGY/S (SNDE), Green Organic Dutchman (TGODF), OrganiGram (OGI), Cronos Group (CRON), Westpac Banking (WBC), Telstra (TLS), Perseus Mining (PRU) and Karoon Energy (KAR).

Who are Mayne Pharma Group's key executives?

Mayne Pharma Group's management team includes the folowing people:
  • Mr. Scott Anthony Richards, MD, CEO & Exec. Director (Age 55)
  • Mr. Nick Freeman BCom, CA, Group CFO & Company Sec.
  • Mr. Stefan J. Cross, Pres of International Operations (Age 46)
  • Dr. Ilana Stancovski, Chief Scientific Officer & Head of European Market Devel.
  • Ms. Lisa Pendlebury, VP of Investor Relations & Communications

What is Mayne Pharma Group's stock price today?

One share of MYX stock can currently be purchased for approximately A$0.46.

How big of a company is Mayne Pharma Group?

Mayne Pharma Group has a market capitalization of $732.95 million and generates $525.21 million in revenue each year. Mayne Pharma Group employs 780 workers across the globe.View Additional Information About Mayne Pharma Group.

What is Mayne Pharma Group's official website?

The official website for Mayne Pharma Group is http://www.maynepharma.com/.

How can I contact Mayne Pharma Group?

Mayne Pharma Group's mailing address is 1538 Main North Rd, ADELAIDE, SA 5106, Australia. The company can be reached via phone at +61-8-82092666.


MarketBeat Community Rating for Mayne Pharma Group (ASX MYX)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  61 (Vote Outperform)
Underperform Votes:  52 (Vote Underperform)
Total Votes:  113
MarketBeat's community ratings are surveys of what our community members think about Mayne Pharma Group and other stocks. Vote "Outperform" if you believe MYX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MYX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel